Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized phase III trial comparing adjuvant oral UFT [tegafur/uracil]/LV [leucovorin; folinic acid] to 5-FU [fluorouracil]/l-LV in stage III colorectal cancer (JCOG-0205-MF)

Next Previous
Trial Profile

Randomized phase III trial comparing adjuvant oral UFT [tegafur/uracil]/LV [leucovorin; folinic acid] to 5-FU [fluorouracil]/l-LV in stage III colorectal cancer (JCOG-0205-MF)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 29 Sep 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Folinic acid (Primary) ; Tegafur/uracil (Primary) ; Fluorouracil
  • Indications Colon cancer; Colorectal cancer
  • Focus Therapeutic Use

Most Recent Events

  • 26 Mar 2013 New source identified and integrated (University Hospital Medical Information Network - Japan, C000000193).
  • 05 Jun 2012 Final results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
  • 15 Dec 2009 Actual patient number (1101) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top